Topic: Cancer treatment
If the project is successful, it would be one of the first targeted treatments for triple-negative breast cancer, with potential for improved survival rates.
This project is a critical step to expand treatment options and could also pave the way for development of immune therapies for breast cancer.
This project would be a significant step forward in development of personalised treatments and should improve survival for this aggressive cancer.
This project will develop vital infrastructure that will make it easier for clinicians to choose the right treatment for individual patients.
The ultimate goal of the project is to inform appropriate care and improve outcomes for pregnant women with cancer and their babies.
If this treatment is shown to be effective, it will provide much-needed hope for patients who receive the devastating diagnosis of pancreatic cancer.
This project will test and validate how new technologies could be utilised to monitor the concentration of chemotherapy in a patient’s blood in real-time.
Prof David Gottlieb’s research has discovered that the treatment of using enhanced white blood cells to fight infection and leukemia can reduce side effects in bone marrow transplant recipients.
A team of researchers led by Dr Nicole Verrills has been investigating if a new ‘gene marker’ can predict which breast cancer patients may have poorer treatment outcomes.
Professor Xu Dong Zhang and his team investigated the role a particular protein plays in melanoma cell survival.